The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Kalnik Matthew W. since year 2005.
The trader's CIK number is 1459477.
At the time of this reporting, Kalnik Matthew W. is the SVP Strategic Plan. of Nabi Biopharmaceuticals .
(stock ticker symbol NABI).
See this page for all insider trading activities at Nabi Biopharmaceuticals .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2010-03-11||NABI||Nabi Biopharmaceuticals||Option Ex||1,125||3.95||4,443|
|2010-03-02||NABI||Nabi Biopharmaceuticals||Option Ex||2,250||3.95||8,887|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kalnik Matthew W. (SVP Strategic Plan. of Nabi Biopharmaceuticals at the time of this reporting) see the Securities and Exchange Commission (SEC) website.